Edward Nash


Otonomy Inc (OTIC): What’s Left After Otividex Disappointment?

Edward Nash Sees Otonomy as a Pure Speculative Pharma Play

Catalyst Pharmaceuticals Inc (CPRX) Shakes Hands with FDA on SPA for Firdapse; SunTrust Chimes In

Though NDA Gets Stalled, Analyst Says Catalyst “Still on Track”

SunTrust Downgrades Cempra Inc (CEMP) Amid Manufacturing Issues; Shares Fall 8%

SunTrust analyst Edward Nash has left the sidelines, downgrading his rating from a Hold to a Sell on Cempra Inc (NASDAQ:CEMP). Nash notes he expects the …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts